October 24, 2012

Forest Laboratories files for FDA approval of new antidepressant drug

Forest Laboratories has filed for marketing approval from the Food and Drug Administration (FDA) for its new antidepressant drug levomilnacipran, which is in the same class of drugs as the antidepressant Effexor. The drugs are classified as serotonin norepinephrine reuptake inhibitors (SNRIs).

Read more about new SNRI antidepressant...

No comments:

Post a Comment